Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PRO-UROKINASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 166 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Selvarajan, S; Lund, LR; Takeuchi, T; Craik, CS; Werb, Z
      A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation

      NATURE CELL BIOLOGY
    2. Konduri, SD; Tasiou, A; Chandrasekar, N; Rao, JS
      Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro

      INTERNATIONAL JOURNAL OF ONCOLOGY
    3. Zhu, H; Liu, W; Shi, W; Xue, YM; Kuai, LT; Ma, Z
      In vitro renaturation of recombinant human pro-urokinase expressed in Escherichia coli

      CHINESE MEDICAL JOURNAL
    4. Motta, G; Shariat-Madar, Z; Mahdi, F; Sampaio, CAM; Schmaier, AH
      Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix

      THROMBOSIS AND HAEMOSTASIS
    5. Poliakov, A; Tkachuk, V; Ovchinnikova, T; Potapenko, N; Bagryantsev, S; Stepanova, V
      Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation

      BIOCHEMICAL JOURNAL
    6. Jiao, JW; Yu, MM; Ru, BG
      Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    7. Schenk-Braat, EAM; Morser, J; Rijken, DC
      Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    8. Kannemeier, C; Feussner, A; Stohr, HA; Weisse, J; Preissner, KT; Romisch, J
      Factor VII and single-chain plasminogen activator-activating protease - Activation and autoactivation of the proenzyme

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    9. Collen, D; Lijnen, HR
      Recent developments in thrombolytic therapy

      FIBRINOLYSIS & PROTEOLYSIS
    10. Ghosh, S; Ellerbroek, SM; Wu, Y; Stack, MS
      Tumor cell-mediated proteolysis: regulatory mechanisms and functional consequences

      FIBRINOLYSIS & PROTEOLYSIS
    11. Rijken, DC; Sakharov, DV
      Molecular transport during fibrin clot lysis

      FIBRINOLYSIS & PROTEOLYSIS
    12. Vines, DJ; Lee, SW; Dichek, DA; Ellis, V
      Receptor-mediated regulation of plasminogen activator function: Plasminogen activation by two directly membrane-anchored forms of urokinase

      JOURNAL OF PEPTIDE SCIENCE
    13. Lijnen, HR; Collen, D
      Molecular basis of thrombolytic therapy

      JOURNAL OF NUCLEAR CARDIOLOGY
    14. Schmaier, AH
      Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions

      CURRENT OPINION IN HEMATOLOGY
    15. Wang, P; Zhang, J; Sun, ZY; Chen, YH; Liu, JN
      Glycosylation of prourokinase produced by Pichia pastoris impairs enzymatic activity but not secretion

      PROTEIN EXPRESSION AND PURIFICATION
    16. Okusa, Y; Ichikura, T; Mochizuki, H; Shinomiya, N
      Urokinase type plasminogen activator and its receptor regulates the invasive potential of gastric cancer cell lines

      INTERNATIONAL JOURNAL OF ONCOLOGY
    17. Gurewich, V
      Fibrinolysis: an unfinished agenda

      BLOOD COAGULATION & FIBRINOLYSIS
    18. Haj-Yehia, A; Nassar, T; Sachais, BS; Kuo, A; Bdeir, K; Al-Mehdi, AB; Mazar, A; Cines, DB; Higazi, AA
      Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo

      FASEB JOURNAL
    19. Aisina, RB; Moukhametova, LI; Firsova, EF; Varfolomeyev, SD
      Prolonged plasma clot lysis induced by acyl-derivatives of urokinase in vitro

      APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
    20. Braat, EAM; Collen, A; Jie, AFH; Grimbergen, JM; Rijken, DC
      The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    21. Wang, P; Zhang, J; Sun, ZY; Chen, YH; Gurewich, V; Liu, JN
      Catalytic and fibrinolytic properties of recombinant urokinase plasminogenactivator from E-coli, mammalian, and yeast cells

      THROMBOSIS RESEARCH
    22. Lee, SL; Dickson, RB; Lin, CY
      Activation of hepatocyte growth factor and urokinase/plasminogen activatorby matriptase, an epithelial membrane serine protease

      JOURNAL OF BIOLOGICAL CHEMISTRY
    23. Bdeir, K; Murciano, JC; Tomaszewski, J; Koniaris, L; Martinez, J; Cines, DB; Muzykantov, VR; Higazi, AAR
      Urokinase mediates fibrinolysis in the pulmonary microvasculature

      BLOOD
    24. Macchione, E; Epifano, O; Stefanini, M; Belin, D; Canipari, R
      Urokinase redistribution from the secreted to the cell-bound fraction in granulosa cells of rat preovulatory follicles

      BIOLOGY OF REPRODUCTION
    25. Ouriel, K; Kandarpa, K; Schuerr, DM; Hultquist, M; Hodkinson, G; Wallin, B
      Prourokinase versus urokinase for recanalization of peripheral occlusions,safety and efficacy: The PURPOSE trial

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    26. Kang, HM; Choi, KS; Kassam, G; Fitzpatrick, SL; Kwon, M; Waisman, DM
      Role of annexin II tetramer in plasminogen activation

      TRENDS IN CARDIOVASCULAR MEDICINE
    27. Mohanam, S; Go, Y; Sawaya, R; Venkaiah, B; Mohan, PM; Kouraklis, GP; Gokaslan, ZL; Lagos, GK; Rao, JS
      Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo

      INTERNATIONAL JOURNAL OF ONCOLOGY
    28. Zhu, FX; He, FC
      Progress in study of structure-function relationship and protein engineering of plasminogen activators

      CHINESE SCIENCE BULLETIN
    29. Michels, HR; Hoffman, JJML; Bar, FWHM
      Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: Comparison of infusion, single-bolus, and split-bolus administration

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    30. Maksimenko, AV; Tischenko, EG
      New thrombolytic strategy: Bolus administration of tPA and urokinase-fibrinogen conjugate

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    31. Jiang, L; Yang, YH; Chatterjee, S; Seidel, B; Wolf, G; Yang, SL
      The expression of proUK in Escherichia coli: The vgb promoter replaces IPTG and coexpression of argU compensates for rare codons in a hypoxic induction model

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    32. Schousboe, I; Feddersen, K; Rojkjaer, R
      Factor XIIa is a kinetically favorable plasminogen activator

      THROMBOSIS AND HAEMOSTASIS
    33. Weitz, JI; Stewart, RJ; Fredenburgh, JC
      Mechanism of action of plasminogen activators

      THROMBOSIS AND HAEMOSTASIS
    34. Monvoisin, A; Neaud, V; De Ledinghen, V; Dubuisson, L; Balabaud, C; Bioulac-Sage, P; Desmouliere, A; Rosenbaum, J
      Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase

      JOURNAL OF HEPATOLOGY
    35. Rojkjaer, R; Schmaier, AH
      Activation of the plasma kallikrein/kinin system on endothelial cell membranes

      IMMUNOPHARMACOLOGY
    36. Ogura, N; Nagura, H; Abiko, Y
      Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide

      JOURNAL OF PERIODONTOLOGY
    37. Braat, EAM; Levi, M; Bos, R; Haverkate, F; Lassen, MR; de Maat, MPM; Rijken, DC
      Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    38. Longstaff, C; Merton, RE; Fabregas, P; Felez, J
      Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)

      BLOOD
    39. VANDERKAADEN ME; RIJKEN DC; VANBERKEL TJC; KUIPER J
      PLASMA-CLEARANCE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      FIBRINOLYSIS & PROTEOLYSIS
    40. GULBA DC; BODE C; RUNGE MS; HUBER K
      THROMBOLYTIC AGENTS - AN UPDATED OVERVIEW

      FIBRINOLYSIS & PROTEOLYSIS
    41. WILHELM S; SCHMITT M; PARKINSON J; KUHN W; GRAEFF H; WILHELM OG
      THROMBOMODULIN, A RECEPTOR FOR THE SERINE-PROTEASE THROMBIN, IS DECREASED IN PRIMARY TUMORS AND METASTASES BUT INCREASED IN ASCITIC FLUIDS OF PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-IIIC

      International journal of oncology
    42. Tsurutani, T; Orita, T; Kitahara, T
      Thrombolytic therapy by pro-Urokinase combined with tissue plasminogen activator in an acute internal carotid occlusion

      JOURNAL OF CLINICAL NEUROSCIENCE
    43. BRAAT EAM; LOS P; RIJKEN DC
      THE INACTIVATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATORBY THROMBIN IN A PLASMA MILIEU - EFFECT OF THROMBOMODULIN

      Blood coagulation & fibrinolysis
    44. GUNZLER WA
      SARUPLASE - BACKGROUND AND BIOCHEMISTRY

      Reviews in contemporary pharmacotherapy
    45. MICHELS HR
      THE IMPORTANCE OF SARUPLASE IN THE CONTEXT OF OTHER THROMBOLYTIC MEDICATIONS

      Reviews in contemporary pharmacotherapy
    46. MUSTJOKI S; TAPIOVAARA H; SIREN V; VAHERI A
      INTERFERONS AND RETINOIDS ENHANCE AND DEXAMETHASONE SUPPRESSES UROKINASE-MEDIATED PLASMINOGEN ACTIVATION IN PROMYELOCYTIC LEUKEMIA-CELLS

      Leukemia
    47. BOUMA BN; VONDEMBORNE PAK; MEIJERS JCM
      FACTOR-XI AND PROTECTION OF THE FIBRIN CLOT AGAINST LYSIS - A ROLE FOR THE INTRINSIC PATHWAY OF COAGULATION IN FIBRINOLYSIS

      Thrombosis and haemostasis
    48. KIENAST J; PADRO T; STEINS M; LI CX; SCHMID KW; HAMMEL D; SCHELD HH; VANDELOO JCW
      RELATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION TO PRESENCE AND SEVERITY OF ATHEROSCLEROTIC LESIONS IN HUMAN CORONARY-ARTERIES

      Thrombosis and haemostasis
    49. INOUE T; HASUMI K; SUGIMOTO M; ENDO A
      ENHANCEMENT OF FIBRINOLYSIS BY PLACTINS - STRUCTURE-ACTIVITY RELATIONSHIP AND EFFECTS IN HUMAN U937 CELLS AND IN MICE

      Thrombosis and haemostasis
    50. Festuccia, C; Dolo, V; Guerra, F; Violini, S; Muzi, P; Pavan, A; Bologna, M
      Plasminogen activator system modulates invasive capacity and proliferationin prostatic tumor cells

      CLINICAL & EXPERIMENTAL METASTASIS
    51. MAKSIMENKO AV
      COMBINED THROMBOLYSIS BY PHARMACOKINETICA LLY DIFFERENT PLASMINOGEN ACTIVATORS

      Bioorganiceskaa himia
    52. COLLSANGRONA E; AROCHAPINANGO CL
      FIBRINOLYTIC ACTION ON FRESH HUMAN CLOTS OF WHOLE-BODY EXTRACTS AND 2SEMIPURIFIED FRACTIONS FROM LONOMIA-ACHELOUS CATERPILLAR

      Brazilian journal of medical and biological research
    53. MALONE MD; BARBER L; COMEROTA AJ
      CLINICAL-APPLICATIONS OF THROMBOLYTIC THERAPY FOR ARTERIAL AND GRAFT OCCLUSION

      The Surgical clinics of North America
    54. FRANCO P; MASSA O; GARCIAROCHA R; CHIARADONNA F; IACCARINO C; CORREAS I; MENDEZ E; AVILA J; BLASI F; STOPPELLI MP
      PROTEIN-KINASE C-DEPENDENT IN-VIVO PHOSPHORYLATION OF PROUROKINASE LEADS TO THE FORMATION OF A RECEPTOR COMPETITIVE ANTAGONIST

      The Journal of biological chemistry
    55. ALEXANDER DS; SIPLEY JD; QUIGLEY JP
      AUTOACTIVATION OF AVIAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) - A NOVEL MODE OF INITIATION OF THE UPA PLASMIN CASCADE/

      The Journal of biological chemistry
    56. FESTUCCIA C; GUERRA F; DASCENZO S; GIUNCIUGLIO D; ALBINI A; BOLOGNA M
      IN-VITRO REGULATION OF PERICELLULAR PROTEOLYSIS IN PROSTATIC TUMOR-CELLS TREATED WITH BOMBESIN

      International journal of cancer
    57. BRUNNER G; REIMBOLD K; MEISSAUER A; SCHIRRMACHER V; ERKELL LJ
      SULFATED GLYCOSAMINOGLYCANS ENHANCE TUMOR-CELL INVASION IN-VITRO BY STIMULATING PLASMINOGEN ACTIVATION

      Experimental cell research
    58. ODA M; SHIRAISHI A; HASEGAWA M
      ANALYSIS OF THE TERNARY COMPLEX-FORMATION OF HUMAN UROKINASE WITH THESEPARATED 2 DOMAINS OF ITS RECEPTOR

      European journal of biochemistry
    59. Cejkova, J
      The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits

      DOCUMENTA OPHTHALMOLOGICA
    60. HIGAZI AA; BDEIR K; HISS E; ARAD S; KUO A; BARGHOUTI I; CINES DB
      LYSIS OF PLASMA CLOTS BY UROKINASE-SOLUBLE UROKINASE RECEPTOR COMPLEXES

      Blood
    61. SUN ZY; LIU BF; CHEN YH; GUREWICH V; ZHU DX; LIU JN
      ANALYSIS OF THE FORCES WHICH STABILIZE THE ACTIVE CONFORMATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      Biochemistry
    62. UGWU F; VANHOEF B; BINI A; COLLEN D; LIJNEN HR
      PROTEOLYTIC CLEAVAGE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY STROMELYSIN-1 (MMP-3)

      Biochemistry
    63. KREKORA K; VITACOLONNA E; DICASTELNUOVO A; DORAZIO A; DELUCIA D; DOOIJEWAARD G; CAPANI F; DONATI MB; IACOVIELLO L
      DECREASE IN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Fibrinolysis & proteolysis
    64. TEBBE U; GUNZLER WA; HOPKINS GR; GRYMBOWSKI T; BARTH H
      THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH SARUPLASE, ASINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) FROM RECOMBINANT BACTERIA

      Fibrinolysis & proteolysis
    65. VANGRIENSVEN JMT; KOSTER RW; HOPKINS GR; BEIER H; GUNZLER WA; KROON R; SCHOEMAKER RC; COHEN AF
      EFFECT OF CHANGES IN LIVER BLOOD-FLOW ON THE PHARMACOKINETICS OF SARUPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Thrombosis and haemostasis
    66. VANDERKAADEN ME; RIJKEN DC; KRUIJT JK; VANBERKEL TJC; KUIPER J
      THE ROLE OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) IN THE PLASMA-CLEARANCE AND LIVER UPTAKE OF RECOMBINANT SINGLE-CHAINUROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN RATS

      Thrombosis and haemostasis
    67. NYKJAER A; CONESE M; CHRISTENSEN EI; OLSON D; CREMONA O; GLIEMANN J; BLASI F
      RECYCLING OF THE UROKINASE RECEPTOR UPON INTERNALIZATION OF THE UPA-SERPIN COMPLEXES

      EMBO journal
    68. SUN ZY; JIANG YP; MA Z; WU H; LIU BF; XU YM; TANG W; CHEN YH; LI CZ; ZHU DX; GUREWICH V; LIU JN
      IDENTIFICATION OF A FLEXIBLE LOOP REGION-(297-313) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, WHICH HELPS DETERMINE ITS CATALYTIC ACTIVITY

      The Journal of biological chemistry
    69. OKUMURA Y; SATO H; SEIKI M; KIDO H
      PROTEOLYTIC ACTIVATION OF THE PRECURSOR OF MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE BY HUMAN PLASMIN - A POSSIBLE CELL-SURFACE ACTIVATOR

      FEBS letters
    70. LENICH C; LIU JN; GUREWICH V
      THROMBIN STIMULATION OF PLATELETS INDUCES PLASMINOGEN ACTIVATION MEDIATED BY ENDOGENOUS UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      Blood
    71. LIN YZ; HARRIS RB; YAN WY; MCCRAE KR; ZHANG H; COLMAN RW
      HIGH-MOLECULAR-WEIGHT KININOGEN PEPTIDES INHIBIT THE FORMATION OF KALLIKREIN ON ENDOTHELIAL-CELL SURFACES AND SUBSEQUENT UROKINASE-DEPENDENT PLASMIN FORMATION

      Blood
    72. ALEXANDER DS; AIMES RT; QUIGLEY JP
      WHAT STRUCTURE AND FUNCTION OF AVIAN PLASMINOGEN-ACTIVATOR AND MATRIXMETALLOPROTEINASE-2 REVEAL ABOUT THEIR COUNTERPART MAMMALIAN ENZYMES,THEIR REGULATION AND THEIR ROLE IN TUMOR INVASION

      Enzyme & protein
    73. MICHELS HR; HOFFMANN JJML; WINDELER J; HOPKINS GR
      HEMOSTATIC CHANGES AFTER THROMBOLYTIC THERAPY WITH SARUPLASE (UNGLYCOSYLATED SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR) AND UROKINASE (2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR)

      Blood coagulation & fibrinolysis
    74. GULBA DC; BODE C; RUNGE MS; HUBER K
      THROMBOLYTIC AGENTS - AN OVERVIEW

      Annals of hematology
    75. GROSSMANN R; EBELL JB; MISOPH M; SCHWENDER S; NEUKAM K; HICKETHIER T; ELERT O; KELLER F
      CHANGES IN COAGULATION AND FIBRINOLYTIC PARAMETERS CAUSED BY EXTRACORPOREAL-CIRCULATION

      Heart and vessels
    76. TSUJIKAWA M; OKABAYASHI K; MORITA M; TANABE T
      SECRETION OF A VARIANT OF HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR WITHOUT AN N-GLYCOSYLATION SITE IN THE METHYLOTROPHIC YEAST, PICHIA-PASTORIS AND CHARACTERIZATION OF THE SECRETED PRODUCT

      Yeast
    77. FOX D; OURIEL K; GREEN RM; STOUGHTON J; RIGGS P; CIMINO C
      THROMBOLYSIS WITH PROUROKINASE VERSUS UROKINASE - AN IN-VITRO COMPARISON

      Journal of vascular surgery
    78. LENGYEL E; GUM R; STEPP E; JUAREZ J; WANG H; BOYD D
      REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION BY AN ERK1-DEPENDENT SIGNALING PATHWAY IN A SQUAMOUS-CELL CARCINOMA CELL-LINE

      Journal of cellular biochemistry
    79. BRAAT EAM; NAULAND U; DOOIJEWAARD G; RIJKEN DC
      A SENSITIVE BIOIMMUNOASSAY FOR THROMBIN-CLEAVED 2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN-BODY FLUIDS

      Thrombosis and haemostasis
    80. TKACHUK V; STEPANOVA V; LITTLE PJ; BOBIK A
      REGULATION AND ROLE OF UROKINASE PLASMINOGEN-ACTIVATOR IN VASCULAR REMODELING

      Clinical and experimental pharmacology and physiology
    81. STRINGER KA
      BIOCHEMICAL AND PHARMACOLOGICAL COMPARISON OF THROMBOLYTIC AGENTS

      Pharmacotherapy
    82. ALLAN EH; MARTIN TJ
      RECEPTOR-MEDIATED EFFECT OF THROMBIN ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 SYNTHESIS IN RAT OSTEOBLAST-LIKE CELLS

      Fibrinolysis
    83. RESNATI M; GUTTINGER M; VALCAMONICA S; SIDENIUS N; BLASI F; FAZIOLI F
      PROTEOLYTIC CLEAVAGE OF THE UROKINASE RECEPTOR SUBSTITUTES FOR THE AGONIST-INDUCED CHEMOTACTIC EFFECT

      EMBO journal
    84. YOSHIMOTO M; USHIYAMA Y; SAKAI M; TAMAKI S; HARA H; TAKAHASHI K; SAWASAKI Y; HANADA K
      CHARACTERIZATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATORWITH A NOVEL AMINO-ACID SUBSTITUTION IN THE KRINGLE STRUCTURE

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    85. HIGAZI AAR; CINES D
      REGULATION OF SINGLE-CHAIN UROKINASE BY SMALL PEPTIDES

      Thrombosis research
    86. BEHRENDT N; DANO K
      EFFECT OF PURIFIED, SOLUBLE UROKINASE RECEPTOR ON THE PLASMINOGEN-PROUROKINASE ACTIVATION SYSTEM

      FEBS letters
    87. HIGAZI AAR; MAZAR A; WANG JY; REILLY R; HENKIN J; KNISS D; CINES D
      SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BOUND TO ITS RECEPTOR IS RELATIVELY RESISTANT TO PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1

      Blood
    88. JIANG YP; PANNELL R; LIU JN; GUREWICH V
      EVIDENCE FOR A NOVEL BINDING-PROTEIN TO UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PLATELET MEMBRANES

      Blood
    89. TANAKA K; EINAGA K; TSUCHIYAMA H; TAIT JF; FUJIKAWA K
      PREPARATION AND CHARACTERIZATION OF A DISULFIDE-LINKED BIOCONJUGATE OF ANNEXIN-V WITH THE B-CHAIN OF UROKINASE - AN IMPROVED FIBRINOLYTIC AGENT TARGETED TO PHOSPHOLIPID-CONTAINING THROMBI

      Biochemistry
    90. CREDO RB; BURKE SE
      FIBRINOLYTIC MECHANISM, BIOCHEMISTRY, AND PRECLINICAL PHARMACOLOGY OFRECOMBINANT PROUROKINASE

      Journal of vascular and interventional radiology
    91. LIJNEN HR; COLLEN D
      MECHANISMS OF PHYSIOLOGICAL FIBRINOLYSIS

      Bailliere's clinical haematology
    92. RIJKEN DC
      PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS - BIOCHEMICAL ASPECTS

      Bailliere's clinical haematology
    93. NORTHEAST ADR; SOO KS; BOBROW LG; GAFFNEY PJ; BURNAND KG
      THE TISSUE-PLASMINOGEN ACTIVATOR AND UROKINASE RESPONSE IN-VIVO DURING NATURAL RESOLUTION OF VENOUS THROMBUS

      Journal of vascular surgery
    94. LENICH C; PANNELL R; GUREWICH V
      ASSEMBLY AND ACTIVATION OF THE INTRINSIC FIBRINOLYTIC PATHWAY ON THE SURFACE OF HUMAN ENDOTHELIAL-CELLS IN CULTURE

      Thrombosis and haemostasis
    95. VANDERKAADEN ME; RIJKEN DC; GROENEVELD E; VANBERKEL TJC; KUIPER J
      NATIVE AND NONGLYCOSYLATED RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ARE RECOGNIZED BY DIFFERENT RECEPTOR SYSTEMS ON RAT PARENCHYMAL LIVER-CELLS

      Thrombosis and haemostasis
    96. VERSTRAETE M
      THE FIBRINOLYTIC SYSTEM - FROM PETRI DISHES TO GENETIC-ENGINEERING

      Thrombosis and haemostasis
    97. LIJNEN HR; COLLEN D
      FIBRINOLYTIC AGENTS - MECHANISMS OF ACTIVITY AND PHARMACOLOGY

      Thrombosis and haemostasis
    98. SPANNAGL M; DOOIJEWAARD G; DIETRICH W; KLUFT C
      PROTECTION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) IN APROTININ TREATED CARDIAC SURGICAL PATIENTS UNDERGOING CARDIOPULMONARY BYPASS

      Thrombosis and haemostasis
    99. BASHKOV GV; JITKOVA JV
      A COMBINATION OF RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE HAS A SYNERGISTIC NON-FIBRIN SPECIFIC ACTION ON IN-VITRO CLOT LYSIS

      Fibrinolysis
    100. GUREWICH V; PANNELL R; LIU JN
      UNTITLED

      Fibrinolysis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 01:33:41